ea0029p785 | Endocrine tumours and neoplasia | ICEECE2012
Hescot S.
, Slama A.
, Paci A.
, Remy H.
, Chadarevian R.
, Trabado S.
, Lombes A.
, Young J.
, Baudin E.
, Lombes M.
Mitotane (o,pDDD) represents the most effective treatment of adrenocortical carcinoma (ACC). However, molecular mechanisms of mitotane action remain poorly understood. Mitochondrial (mt) impact of mitotane has previously been suggested but not yet fully validated. We investigated functional consequences of mitotane exposure on mitochondrial steroidogenesis, respiratory chain activity and biogenesis, using human adrenocortical secreting H295R and non-secreting SW13 cells....